Recent studies of myoglobin (Mb) knockout (myo -/-) mice have extended our understanding of Mb's diverse functions and have demonstrated a complex array of compensatory mechanisms. The present study was aimed at detailed analysis of cardiac function and exercise endurance in myo -/-mice and at providing evidence for Mb's functional relevance. Myo -/-isolated working hearts display decreased contractility (dP/dtmax 3883±351 vs. 4618±268 mmHg/sec, myo -/-vs. WT, P<0.005). Due to a shift in sympathetic/parasympathetic tone, heart rate is reduced in conscious myo mice -/-(615±33 vs. 645±27 bpm, myo -/-vs. WT, P<0.001). Oxygen consumption (VO 2 ) under resting conditions (3082±413 vs. 4452±552 ml*kg -1 *h -1 , myo -/-vs. WT, P<0.001) and exercise endurance, as determined by spiroergometry, are decreased (466±113 vs. 585±153 m, myo -/-vs. WT, P<0.01). Conscious myo -/-mice evaluated by echocardiography display lowered cardiac output (0.64±0.06 vs. 0.75±0.09 ml*min -1 *g -1 , myo -/-vs. WT, P<0.001), impaired systolic shortening (60±3.5 vs. 65±4%, myo -/-vs. WT, P<0.001) and fail to respond to β 1 -stimulation. Strikingly, the latter cardiac effects of Mb deficiency can be partially attenuated by NOS inhibition. Loss of Mb results in a distinct phenotype, even under resting conditions, and the importance of oxygen supply and nitric oxide scavenging by Mb is clearly demonstrated at the conscious animal level.
have proved challenging and yielded results somewhat conflicting due to the relatively low diffusion constant for Mb in skeletal muscle reported by Papadopoulos et al. (8) . Recent direct evidence positioning Mb as a link between capillary O 2 supply and the O 2 -consuming mitochondrial cytochromes was produced, using myo -/-mice as appropriate controls (9) . Supportive evidence was derived from observations on isolated cardiomyocytes (9) (10) (11) .
With the general acceptance of hemoglobin's crucial role in oxidative NO inactivation by reaction to nitrate and methemoglobin, a similar function might be expected for intracellular Mb. In fact, experimental evidence was recently presented characterizing Mb as an important intracellular NO scavenger-substantially determining the dose-response curve of NO effects on coronary flow and cardiac contractility (12) . In addition, we could demonstrate that Mb's scavenging capacity extends to reactive oxygen species thus providing a novel antioxidant defense mechanism (13) .
Initial evaluation of myo -/-mice revealed a benign phenotype with exercise capacity as well as skeletal and cardiac muscle function unaltered (2) . We demonstrated a surprising array of compensatory mechanisms, all aimed at steepening the intracellular PO 2 gradient. These include a higher capillary density and decreased cardiomyocyte width, increased coronary flow and flow reserve, as well as elevated hematocrit (3, 9) . Together, the above findings led to the belief that myo -/-mice were characterized by a fully compensated phenotype. However, none of the previous studies included a detailed analysis of cardiac function and exercise capacity (2, 3, 9, (12) (13) (14) . The purpose of the present study was, therefore, to characterize the cardiac and hemodynamic phenotype of myo -/-mice under resting and exercise conditions and thus further elicit Mb's diverse functions. To this end, we used an isolated working heart model employing a wide range of loading conditions. We evaluated cardiac function in vivo by (stress-) echocardiography of conscious myo -/-and WT mice with and without concurrent NO-synthase (NOS) inhibition. In addition, mice were placed in metabolic chambers and O 2 consumption (VO 2 ) and CO 2 production (VCO 2 ) were measured. Finally, for the determination of exercise endurance and anaerobic threshold, mice were subjected to spiroergometric analysis.
MATERIALS AND METHODS

Animals
Myo
-/--mice were backcrossed for seven generations onto the NMRI background as described previously (3) . Male mice were used throughout the experiments, and all studies were performed at the same time of day (17:00 to 21:00) to obviate circadian influences.
Working heart setup and protocol
Preparation of murine hearts and retrograde perfusion at 100 mmHg constant pressure with modified Krebs-Henseleit buffer were performed essentially as described (9) .
The isolated heart apparatus used (Hugo Sachs Elektronik, March-Hugstetten, Germany) allowed the adjustment of preload (3 to 25 mmHg) and of afterload (15 to 250 mmHg). Afterload, preload, atrial flow, aortic flow, and left ventricular pressure (LVP) were measured continuously using a personal computer with analog-digital converter (2000 Hz) and dedicated software (EMKA Technologies, Paris, France). Derivative parameters (dP/dt max , dP/dt min , coronary flow, tau, RT 1/2 , and TPP) were displayed in real time and recorded. Hearts from myo -/-and WT mice (n=14, respectively, 29±5 vs. 30±3 g, P=n.s.) were subjected to increasing preload (5, 6, 8, 10 mmHg), while afterload remained at 80 mmHg. Hereafter, preload was fixed at 8 mmHg, and afterload increased in 10 mmHg steps from 50 to 120 mmHg.
Echocardiography
Conscious myo -/-and WT mice (n=24, respectively, 33±2 vs. 34±3 g, P=n.s.) were examined by echocardiography as described previously (15) . To avoid bradycardia, seen occasionally when performing echocardiography in awake mice, mice were trained to tolerate the handling associated with echocardiographic examination on three to four separate occasions per day over a period of three days. After this training period, all mice remained calm during the examination. If image recording of sufficient quality could not be initiated within 2 min, the animal was allowed to rest and images were obtained at a later time to ensure minimal time span of animal handling.
With a 12 MHz transducer with 20 mm standoff connected to a Sonos 5500™ (Phillips Medical Systems; frequency fusion: 5; interrogation depth 3 cm), the heart was imaged in twodimensional (2D) mode in the parasternal long axis view and 2D guided M-mode images were obtained at the level of the papillary muscles for measurement of wall thickness and chamber dimensions. Aortic dimensions were obtained at the aortic root. Aortic flow velocity was measured with pulsed-wave Doppler after moving to the apical long axis and obtaining an image plane where the aorta was clearly visualized (equivalent to the five chamber view in humans).
Offline evaluation was performed as described recently (16) . In brief, end-diastolic (LVEDD), end-systolic (LVESD) left ventricular dimensions, as well as interventricular septum (IVST) and posterior wall thickness (PWT), were measured in the same M-mode frozen image frame, according to recommendations of the American Society of Echocardiography.
Fractional shortening (SF), a measure of LV systolic function, was calculated using the equation
Aortic flow velocity time integral (VTI) and aortic root dimension (AoD) were obtained from the respective frozen images as above and mean values from three to six heartbeats used for further analysis. Cardiac output (CO) was calculated from the following equations:
2 * π ; SV = CSA * VTI ; CO = SV * HR where CSA is aortic cross-sectional area, SV is stroke volume, and HR is heart rate.
In 12 animals per group, the same procedure was followed for echocardiography involving dobutamine (1.5 µg/gBW, Solvay, Hannover, Germany) and atropine (0.1 µg/gBW, Braun, Melsungen, Germany) application. Images were obtained within 7 and 11 min after intraperitoneal injection, a timeframe shown to represent the plateau pharmacological effect in preliminary experiments. For the remaining 12 animals per group, the same measurements were performed after NOS inhibition was achieved by continuous infusion of 2-ethyl-2-thiopseudourea hydrobromide (ETU) (10.0 µg/gBW/h, Aldrich, Milwaukee, WI) with osmotic mini pumps (Alza, Palo Alto, Ca) implanted into the peritoneal cavity.
Metabolic chambers and treadmill exercise
O 2 consumption (VO 2 ) and CO 2 production (VCO 2 ) were measured in myo -/-and WT mice (n=12, respectively, 33±2 vs. 34±3 g, P=n.s.) under resting and exercise conditions. For measurements at rest, mice were placed in specifically designed individual metabolic chambers and allowed to adjust for 60 min. Following this period, VO 2 and VCO 2 were measured over a period of 4 h with measurements repeated every 10 min for a sample duration of 90 s per mouse and measurement.
The treadmill consisted of four individual lanes enclosed in separate chambers. Each chamber was connected to an Oxymax O 2 and CO 2 gas analyzer, allowing the measurement of VO 2 and VCO 2 (Columbus Instruments, Ohio). Prior to the actual exercise study, mice were trained on three separate occasions to run on the treadmill (inclination constant at 14°) with shock plate incentive (3 Hz, 200 msec, 160 V, 1.5 mA). For the actual study, mice were placed on the stationary belt and left to acclimatize for 30 min. Baseline measurements were then recorded. Hereafter, initial belt speed was set to 10 m/min and increased every 5 min by 2 m/min to a maximum of 20 m/min. Mice were allowed to run until they displayed signs of exhaustion (>2 s spent on the shocker plate without attempting to reengage the treadmill).
Statistical analysis
Mean values with appropriate standard deviation (SD) are reported. Differences in repeated measurements were analyzed by multivariate ANOVA followed by Bonferroni's post hoc test. Otherwise, a student's t test was applied (all statistical analysis calculated with SPSS 10.0, SPSS, Chicago).
RESULTS
Working heart experiments
Weights of excised hearts ranged from 180-250 mg, with no significant differences between WT and myo -/-. Left ventricular mass (including septum) as a percentage of whole heart wet weight was similar (64.7±2.1 vs. 65.3±2.7%; WT vs. myo -/-; P=n.s.).
Afterload was increased stepwise to simulate growing systemic resistance. As listed in Table 1 , impaired contractility was demonstrated by slower contraction and relaxation reflected as time to peak pressure (TPP) and relaxation half-time (RT 1/2 ) in myo -/-hearts. As a further sign of decreased contractility, the maximum rate of pressure development (dP/dt max ) was slower in myo -/-hearts at all afterloads studied. Intrinsic heart rate (HR), left ventricular developed pressure (LVDP), and pressure volume work (cardiac power) observed at the different degrees of afterload (pressure load) did not differ. Figure 1 depicts the parallel coronary flow pattern observed in both groups at increasing afterloads. However, coronary flow in myo -/-hearts was almost twice the rate compared with WT hearts at the respective afterloads. As cardiac output (CO) was not increased in myo -/-hearts, resulting aortic flow was considerably smaller, even approaching zero at the highest afterload employed (120 mmHg).
Stepwise increase in preload was performed to analyze the influence of filling pressure on the given mouse hearts. Intrinsic HR, LVDP, and pressure volume work (cardiac power) observed at the different degrees of preload (volume load) did not differ and rose only slightly with growing preload (data not shown). Coronary flow remained stable at the various preloads studied (Fig. 1) while being ~55% higher in myo -/-hearts compared with their WT counterparts, i.e., 20.2±2.0 ml*min -1 *g -1 vs. 13.0 ± 1.9 ml*min -1 *g -1 (P<0.001) at 5 mmHg preload. With CO identical in both groups, aortic flow was significantly smaller in myo -/-hearts compared with WT hearts, i.e., 14.7 ± 3.3 ml*min -1 *g -1 vs. 23.4 ± 5.7 ml*min -1 *g -1 (P<0.005) at 5 mmHg preload. The lower aortic flow values found for myo -/-hearts reflect the larger fraction of CO required to adequately perfuse the coronaries of myo -/-hearts ( Fig. 1) .
Despite the absence of significant differences in LVDP and cardiac power between the two groups (data not shown), a marked decrease in contractility was detected in myo -/-hearts at all preloads studied. This contractile impairment was especially pronounced at low preloads. For example, dP/dt max at 5 mmHg preload was 4688 ± 425 mmHg/sec in myo -/-hearts vs. 5718 ± 435 mmHg/sec in wild-type hearts (P<0.001) while at 10 mmHg preload the difference in dP/dt max between the respective hearts narrowed to 6001 ± 476 mmHg/sec vs. 6447 ± 547 mmHg/sec (P<0.05).
Echocardiographic analysis
To investigate whether the depressed contractility observed in the working heart model could also be demonstrated in vivo, echocardiographic studies on conscious mice were performed. After the initial training sessions (see Materials and Methods), all animals remained calm during the entire examination. 2D and M-mode images as well as 2D image guided Doppler flow studies were obtained within an average of 3 ± 1 min. As the baseline measurements depicted in Fig. 2 demonstrate, HR and fractional shortening (SF) were significantly depressed in myo -/-mice. As a result, CO of myo -/-mice did not reach the level of their WT counterparts.
To address the possibility of decreased contractility being mediated by higher levels of bioactive NO, NOS inhibition was achieved through continuous 2-ethyl-2-thiopseudourea hydrobromide (ETU) secretion by mini-pumps implanted into the peritoneal cavity. SF increased by 7% in myo -/-mice, thus reaching the level of WT mice, which remained unaffected.
Upon dobutamine stimulation, WT mice responded with a marked increase in CO by 27%, a 15% increase in SF, and an 8% increase in HR, as measured by stress echocardiography. In contrast, myo -/-mice showed only a slight increase of SF and HR (P=n.s.) with limited CO augmentation in comparison to WT mice. However, when NOS was inhibited by ETU, myo -/-mice were capable of SF values equal to those of WT animals and demonstrated a marked increase of CO, albeit not to the level of WT mice, partially due to lower HR observed at baseline and during β 1 stimulation.
To test whether the observed decrease in HR might be due to a shift in sympathetic/parasympathetic tone, ablation of parasympathetic tone was performed (atropine 0.1 µg/g). Seven minutes after atropine application, a remarkable HR of above 800 bpm was measured by echocardiography in conscious myo -/-and WT animals. SF was decreased in both groups secondary to decreased diastolic filling, resulting in CO well below the values observed after dobutamine stimulation.
Metabolic chamber and treadmill exercise
WT and myo -/-mice were placed in metabolic chambers and allowed to adjust for 60 min. Average O 2 consumption (VO 2 ) and respiratory exchange ratio (RER = VCO 2 divided by VO 2 ) are depicted as scatter plot for each mouse studied in Fig. 3 . Though VO 2 varied widely between individual mice due to differences in activity level during the time spent in the metabolic chamber, it is apparent that average VO 2 was higher in WT mice (see also Fig. 4) . Another astounding finding from these measurements is that RER was higher in myo -/-mice for any given VO 2 .
In spiroergometric analysis, all mice could perform exercise for several minutes while subjected to increasing workloads. However, myo -/-mice had earlier onset of fatigue, with mean endurance reduced by an average of 6 min (31±5 vs. 37±7 min, myo -/-vs. WT, P<0.01, n=12 per group). Distance run was calculated to be decreased by an average of ~120 m to 466±113 m in myo -/-mice (WT 585±153 m, P<0.01, n=12 per group).
At rest, VO 2 was decreased in myo -/-mice by 31% to 3082 ± 413 ml/kg/h (P<0.001, Fig. 3 ). With the initiation of exercise, VO 2 in both groups rose sharply, reaching a similar level of maximum VO 2 (Fig. 4) . In contrast, RER at rest was higher in myo -/-than in WT mice (0.85±0.06 vs. 0.75±0.06, P<0.001, n=12 per group Fig. 3) . Furthermore, exercising myo -/-mice showed a significantly larger increase in RER, rising to levels as high as 0.94 (P<0.001, n=12 per group, Fig, 4 ).
DISCUSSION
Myo
-/-mice have been evaluated in several previous studies (2, 3, 9, 12-14). These provided evidence for Mb functioning as short term oxygen reservoir (9) , as facilitator of oxygen diffusion (9) and as scavenger of NO (12) and reactive oxygen species (13) . The present study is the first to demonstrate Mb's functional relevance on the whole animal level in that loss of Mb leads to impaired myocardial contractile function and exercise endurance.
Myocardial oxygen demand at growing workloads is met by increased coronary flow through auto-regulation of vascular bed resistance. However, coronary flow in myo -/-hearts, already significantly enhanced compared with WT in the Langendorff experiments [by approx. 30% (3, 9) ], was even more profoundly increased (by 50 to 100%, depending on loading conditions) in the working heart setup. With CO closely matched in myo -/-and WT hearts, the compensatory increase of coronary flow observed in myo -/-hearts under all conditions studied, comes at the cost of significantly reduced effective output, measured as aortic flow. The consequences are especially striking at high afterloads (120 mmHg): WT hearts manage an effective output of 10 ml*min -1 *g -1 , but effective output in myo -/-hearts approaches zero.
Taking into account the recent discovery of functionally important NO scavenging by Mb (12), increased levels of bioactive NO in myo -/-hearts should be expected to contribute significantly to the high coronary flow observed in myo -/-hearts. Indeed, we were previously able to demonstrate that myo -/-hearts respond far more sensitively to authentic NO solutions and to increased endogenous NO release after bradykinin stimulation than WT hearts (12) . In addition, NOS inhibition by ETU and L-NMMA led to a twofold increase in coronary vascular resistance in myo -/-compared with WT hearts, respectively (12) . The higher capillary density shown earlier to be a compensating mechanism in myo -/-mice (3) might also contribute to the increased coronary flow in myo -/-hearts, albeit to a small degree as apparent from previous adenosine experiments, which led to equal NO-independent vasodilatation in WT and myo -/-hearts.
Despite unimpaired left ventricular developed pressure (LVDP) and CO measured in isolated working myo -/-hearts, dP/dt was lower in myo -/-hearts under all conditions studied. The decreased contractility with increased time to peak pressure (TPP) and relaxation halftime (RT 1/2 ) implies that contraction and relaxation span a longer time period, thereby smoothing the peaks in energy and O 2 demand. This decreased contractility, in itself, might also be viewed as functional adaptation, as it counterbalances the loss of two major Mb functions: mass transport of O 2 by facilitated diffusion and rapid deployment of O 2 from Mb storage.
The dampened contractility observed in working myo -/-hearts in vitro is paralleled by the decreased SF seen in echocardiograms of conscious myo -/-mice. It is conceivable that this decreased contractility is partly mediated by higher levels of bioactive NO due to the lack of Mb's NO scavenging capacity in myo -/-mice (12). These higher bioactive NO levels possibly lead to direct mitochondrial respiratory chain inhibition by NO [for review see Brown et al. (17) ] and thus to impaired ATP generation. Indeed, in the present study pharmacological NOS inhibition leads to recovery of contractility in myo -/-mice in vivo. Furthermore, the dampened response to β 1 -stimulation observed in myo -/-mice is also partly reversible by NOS inhibition. Studying isolated hearts perfused in a retrograde fashion according to Langendorff, we have previously found contractile impairment of myo -/-hearts in response to both the application of authentic NO solution and to stimulation of eNOS by bradykinin (12) . While these findings clearly suggest NO as contributing factor toward cardiovascular alterations in myo -/-mice, it is difficult to assess the degree of NO contribution in vivo as acute NOS inhibition has a multitude of effects on hemodynamics, including altered cardiac loading conditions. Recent studies have demonstrated decreased contractility mediated by NO in transplanted human cardiac tissue (18) . In agreement with our findings, NO mediated contractility alterations in human hearts were characterized by an impaired response to β 1 stimulation (19) . It is interesting to note that low Mb levels (20) and up-regulation of iNOS have been reported in heart failure (21) . Thus, the loss of Mb and resulting lowered O 2 supply in conjunction with the reduced NO scavenging capacity in failing hearts might contribute to the pathophysiology of this frequent disease state. In this context, it is important to point out the tremendous NO scavenging capacity Mb constitutes: recent studies in iNOS overexpressing mice have demonstrated a surprisingly benign phenotype (15) with acute inhibition of Mb being required to demonstrate contractile dysfunction (22) . Furthermore, in studies of iNOS overexpressing mice that were concomitantly Mb deficient, we recently demonstrated that even Mb concentrations lowered by half, as found in heterozygous Mb mice, were sufficient to cope with the significantly increased NO levels associated with iNOS overexpression (23) .
An important difference between our in vivo and in vitro results is found in the HR obtained during echocardiography: While intrinsic HR did not differ in isolated hearts, it was significantly lower in intact myo -/-mice. Given that systemic arterial pressure and thus resistance is unaltered in myo -/-compared with WT mice, the decreased HR would contribute to lowering cardiac O 2 demand in myo -/-mice, thus further cushioning reduced O 2 availability. In line with this hypothesis, this study reports VO 2 of conscious animals at rest to be lower in myo -/-mice than their WT counterparts. The decrease in HR of myo −/− mice is achieved by a shift in sympathetic/parasympathetic tone toward the latter, as demonstrated by our atropine experiments. As the application of ETU reveals, this shift in sympathetic/parasympathetic tone is not NO mediated. Nevertheless, the possible direct inhibition of the mitochondrial respiratory chain due to higher biologically active NO levels in myo -/-mice might also be viewed as an endogenous modulator of oxidative phosphorylation to reduce O 2 consumption under conditions of diminished O 2 supply.
As a further aspect, the increase in RER values of myo -/-mice at any given rate of VO 2 under resting conditions (Fig. 3) points at a shift in substrate utilization toward glucose metabolism and, thus, toward more oxygen efficient metabolism in myo -/-mice. This, in itself, establishes an additional adaptation to decreased oxygen availability in myo -/-mice.
In spite of these multiple functional and morphological compensating mechanisms, in vivo analysis of conscious animals also reveals their limitations: in echocardiographic measurements, myo -/-mice can achieve the cardiac output mustered by WT mice. In addition, myo -/-mice fall short in exercise endurance. This occurs despite their ability to increase VO 2 to the level of WT mice if challenged by the same degree of exercise stress. Moreover, the latter implies a larger absolute increase in VO 2 if one takes into account that VO 2 of the whole animal is ~25% lower in resting myo -/-mice.
A possible cause for the decreased exercise endurance in spite of equal maximum VO 2 is found when analyzing the respiratory exchange ratio (RER). With RER defined as the (VCO 2 ) divided by VO 2 at any given time, it depends on substrate metabolism as discussed above. However, under exercise conditions it also offers an indicator of lactic acid production as anaerobic metabolism supplements aerobic metabolism with rising exercise intensities. The lactic acid produced during exercise from anaerobic metabolism mainly in striated muscle promotes CO 2 formation via the serum bicarbonate buffer in addition to the CO 2 derived from aerobic metabolism, thus shifting the stoichiometric relation with respect to O 2 uptake. Thus RER rises with increasing workload until exhaustion (24, 25) . In our studies, both myo -/-and WT mice displayed considerable increase of RER in the course of exertion. However, RER rose to significantly higher levels in myo -/-mice even though workload was lower and exercise duration shorter. Although a metabolic shift is present in myo -/-mice as discussed above, the accelerated RER rise, in conjunction with the diminished endurance, suggests that anaerobic metabolism contributes to meet the energetic demand in myo -/-mice after shorter periods of exertion and at lower levels of work load compared with WT mice.
In summary, the importance of oxygen supply and NO scavenging by Mb on the conscious animal level is clearly demonstrated, thus expanding our previous observations (9, 12, 13) . Cardiac function and exercise endurance of myo -/-mice are impaired. Lack of Mb results in a substrate utilization shift toward glucose metabolism. Decreased VO 2 in myo -/-mice is facilitated by higher parasympathetic tone. The cardiac dysfunction in myo -/-mice discovered here, namely decreased contractility and fractional shortening as well as subdued response to β 1 stimulation, is partly attenuated by NOS inhibition.
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